{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T02:05:26Z","timestamp":1794449126256,"version":"4.9.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T00:00:00Z","timestamp":1724716800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","award":["Z231100007223012"],"award-info":[{"award-number":["Z231100007223012"]}],"id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-51571-8","type":"journal-article","created":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:02:47Z","timestamp":1724738567000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatment"],"prefix":"10.1038","volume":"15","author":[{"given":"Xinzhu","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingping","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Buyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9061-4481","authenticated-orcid":false,"given":"Hanqiu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5607-5509","authenticated-orcid":false,"given":"Wenzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengxia","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhe","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueguang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Jie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunde","family":"Xian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8030-7672","authenticated-orcid":false,"given":"Derfogail","family":"Delcassian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,8,27]]},"reference":[{"key":"51571_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41577-021-00639-3","volume":"22","author":"T Huby","year":"2022","unstructured":"Huby, T. & Gautier, E. L. Immune cell-mediated features of non-alcoholic steatohepatitis. Nat. Rev. Immunol. 22, 429\u2013443 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"51571_CR2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nrd.2015.3","volume":"15","author":"G Musso","year":"2016","unstructured":"Musso, G., Cassader, M. & Gambino, R. Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies. Nat. Rev. Drug Discov. 15, 249\u2013274 (2016).","journal-title":"Nat. Rev. Drug Discov."},{"key":"51571_CR3","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1136\/gutjnl-2019-319104","volume":"69","author":"JF Dufour","year":"2020","unstructured":"Dufour, J. F., Caussy, C. & Loomba, R. Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges. Gut 69, 1877\u20131884 (2020).","journal-title":"Gut"},{"key":"51571_CR4","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/j.jhep.2021.08.011","volume":"75","author":"T Yang","year":"2021","unstructured":"Yang, T. et al. Therapeutic HNF4A mRNA attenuates liver fibrosis in a preclinical model. J. Hepatol. 75, 1420\u20131433 (2021).","journal-title":"J. Hepatol."},{"key":"51571_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-20903-3","volume":"12","author":"F Rizvi","year":"2021","unstructured":"Rizvi, F. et al. Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNA. Nat. Commun. 12, 613 (2021).","journal-title":"Nat. Commun."},{"key":"51571_CR6","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/s41565-020-00836-6","volume":"16","author":"M Hu","year":"2021","unstructured":"Hu, M. et al. Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis. Nat. Nanotechnol. 16, 466\u2013477 (2021).","journal-title":"Nat. Nanotechnol."},{"key":"51571_CR7","doi-asserted-by":"publisher","first-page":"e015748","DOI":"10.1161\/JAHA.119.015748","volume":"9","author":"T Devarakonda","year":"2020","unstructured":"Devarakonda, T. et al. B7-33, a functionally selective relaxin receptor 1 agonist, attenuates myocardial infarction-related adverse cardiac remodeling in mice. J. Am. Heart Assoc. 9, e015748 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"51571_CR8","doi-asserted-by":"publisher","first-page":"e013465","DOI":"10.1161\/JAHA.119.013465","volume":"8","author":"J Sun","year":"2019","unstructured":"Sun, J. et al. Human relaxin-2 fusion protein treatment prevents and reverses isoproterenol-induced hypertrophy and fibrosis in mouse heart. J. Am. Heart Assoc. 8, e013465 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"51571_CR9","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1021\/acsptsci.3c00053","volume":"6","author":"MA Hossain","year":"2023","unstructured":"Hossain, M. A. et al. Development of novel high-affinity antagonists for the relaxin family peptide receptor 1. ACS Pharm. Transl. Sci. 6, 842\u2013853 (2023).","journal-title":"ACS Pharm. Transl. Sci."},{"key":"51571_CR10","doi-asserted-by":"publisher","first-page":"672658","DOI":"10.3389\/fmed.2021.672658","volume":"8","author":"HT Nga","year":"2021","unstructured":"Nga, H. T. et al. Interleukin-10 attenuates liver fibrosis exacerbated by thermoneutrality. Front. Med. 8, 672658 (2021).","journal-title":"Front. Med."},{"key":"51571_CR11","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41551-021-00797-8","volume":"5","author":"B Zhang","year":"2021","unstructured":"Zhang, B. et al. Site-specific PEGylation of interleukin-2 enhances immunosuppression via the sustained activation of regulatory T cells. Nat. Biomed. Eng. 5, 1288\u20131305 (2021).","journal-title":"Nat. Biomed. Eng."},{"key":"51571_CR12","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","volume":"374","author":"A Astrup","year":"2009","unstructured":"Astrup, A. et al. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 374, 1606\u20131616 (2009).","journal-title":"Lancet"},{"key":"51571_CR13","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41551-020-0549-2","volume":"4","author":"A Mansurov","year":"2020","unstructured":"Mansurov, A. et al. Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours. Nat. Biomed. Eng. 4, 531\u2013543 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"51571_CR14","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1126\/science.1247663","volume":"343","author":"M Martino","year":"2014","unstructured":"Martino, M. et al. Growth factors engineered for super-affinity to the extracellular matrix enhance tissue healing. Science 343, 885\u2013888 (2014).","journal-title":"Science"},{"key":"51571_CR15","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1038\/s41551-023-01025-1","volume":"7","author":"E Bracho-Sanchez","year":"2023","unstructured":"Bracho-Sanchez, E. et al. Suppression of local inflammation via galectin-anchored indoleamine 2,3-dioxygenase. Nat. Biomed. Eng. 7, 1156\u20131169 (2023).","journal-title":"Nat. Biomed. Eng."},{"key":"51571_CR16","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.omtn.2021.03.008","volume":"24","author":"N Davies","year":"2021","unstructured":"Davies, N. et al. Functionalized lipid nanoparticles for subcutaneous administration of mRNA to achieve systemic exposures of a therapeutic protein. Mol. Ther. Nucl. Acids 24, 369\u2013384 (2021).","journal-title":"Mol. Ther. Nucl. Acids"},{"key":"51571_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41565-020-0669-6","volume":"15","author":"Q Cheng","year":"2020","unstructured":"Cheng, Q. et al. Selective organ targeting (SORT) nanoparticles for tissue-specific mRNA delivery and CRISPR-Cas gene editing. Nat. Nanotechnol. 15, 313\u2013320 (2020).","journal-title":"Nat. Nanotechnol."},{"key":"51571_CR18","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1038\/s41565-023-01453-9","volume":"18","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y. et al. Close the cancer-immunity cycle by integrating lipid nanoparticle-mRNA formulations and dendritic cell therapy. Nat. Nanotechnol. 18, 1364\u20131374 (2023).","journal-title":"Nat. Nanotechnol."},{"key":"51571_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-29186-8","volume":"13","author":"J Lee","year":"2022","unstructured":"Lee, J., Byun, J., Shim, G. & Oh, Y. K. Fibroblast activation protein activated antifibrotic peptide delivery attenuates fibrosis in mouse models of liver fibrosis. Nat. Commun. 13, 1516 (2022).","journal-title":"Nat. Commun."},{"key":"51571_CR20","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nbt1396","volume":"26","author":"Y Sato","year":"2008","unstructured":"Sato, Y. et al. Resolution of liver cirrhosis using vitamin A\u2013coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat. Biotechnol. 26, 431\u2013442 (2008).","journal-title":"Nat. Biotechnol."},{"key":"51571_CR21","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13075-019-2075-8","volume":"21","author":"K Katsumata","year":"2019","unstructured":"Katsumata, K. et al. Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-\u03b1 antibody in a murine model of rheumatoid arthritis. Arthritis Res. Ther. 21, 298 (2019).","journal-title":"Arthritis Res. Ther."},{"key":"51571_CR22","doi-asserted-by":"crossref","unstructured":"Seo, Y. et al. Recent progress of lipid nanoparticles-based lipophilic drug delivery: focus on surface modifications. Pharmaceutics 15, 772 (2023).","DOI":"10.3390\/pharmaceutics15030772"},{"key":"51571_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.bbalip.2008.11.001","volume":"1791","author":"WS Blaner","year":"2009","unstructured":"Blaner, W. S. et al. Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. BBA Mol. Cell Biol. L 1791, 467\u2013473 (2009).","journal-title":"BBA Mol. Cell Biol. L"},{"key":"51571_CR24","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1146\/annurev-pharmtox-052120-104428","volume":"62","author":"LJ Gudas","year":"2022","unstructured":"Gudas, L. J. Synthetic retinoids beyond cancer therapy. Annu. Rev. Pharmacol. Toxicol. 62, 155\u2013175 (2022).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"51571_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1096\/fasebj.7.12.8375617","volume":"7","author":"R Berni","year":"1993","unstructured":"Berni, R., Clerici, M., Malpell, G., Cleris, L. & Formelli, F. Retinoids: in vitro interaction with retinol-binding protein and influence on plasma retinol. FASEB J. 7, 6 (1993).","journal-title":"FASEB J."},{"key":"51571_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14527-2","volume":"11","author":"S Patel","year":"2020","unstructured":"Patel, S. et al. Naturally-occurring cholesterol analogues in lipid nanoparticles induce polymorphic shape and enhance intracellular delivery of mRNA. Nat. Commun. 11, 983 (2020).","journal-title":"Nat. Commun."},{"key":"51571_CR27","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jcmgh.2020.07.006","volume":"11","author":"A Saeed","year":"2021","unstructured":"Saeed, A. et al. Impaired hepatic vitamin A metabolism in NAFLD mice leading to vitamin A accumulation in hepatocytes. Cell. Mol. Gastroenterol. Hepatol. 11, 309\u2013325.e303 (2021).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"51571_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/s41586-022-05289-6","volume":"610","author":"A Filliol","year":"2022","unstructured":"Filliol, A. et al. Opposing roles of hepatic stellate cell subpopulations in hepatocarcinogenesis. Nature 610, 356\u2013365 (2022).","journal-title":"Nature"},{"key":"51571_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/nprot.2015.017","volume":"10","author":"I Mederacke","year":"2015","unstructured":"Mederacke, I., Dapito, D. H., Aff\u00f2, S., Uchinami, H. & Schwabe, R. F. High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers. Nat. Protoc. 10, 305\u2013315 (2015).","journal-title":"Nat. Protoc."},{"key":"51571_CR30","doi-asserted-by":"publisher","first-page":"20180156","DOI":"10.1098\/rstb.2018.0156","volume":"374","author":"AS Desai","year":"2019","unstructured":"Desai, A. S., Hunter, M. R. & Kapustin, A. N. Using macropinocytosis for intracellular delivery of therapeutic nucleic acids to tumour cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 374, 20180156 (2019).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"51571_CR31","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","volume":"31","author":"J Gilleron","year":"2013","unstructured":"Gilleron, J. et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31, 638\u2013646 (2013).","journal-title":"Nat. Biotechnol."},{"key":"51571_CR32","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1021\/acs.jpcb.7b10795","volume":"122","author":"J Viger-Gravel","year":"2018","unstructured":"Viger-Gravel, J. et al. Structure of lipid nanoparticles containing siRNA or mRNA by dynamic nuclear polarization-enhanced NMR spectroscopy. J. Phys. Chem. B 122, 2073\u20132081 (2018).","journal-title":"J. Phys. Chem. B"},{"key":"51571_CR33","doi-asserted-by":"publisher","unstructured":"Ge, Y., Boopathy, S., Smith, A. & Chao, L. H. A model membrane platform for reconstituting mitochondrial membrane dynamics. J. Vis. Exp. 163, e61620 https:\/\/doi.org\/10.3791\/61620 (2020).","DOI":"10.3791\/61620"},{"key":"51571_CR34","doi-asserted-by":"crossref","unstructured":"Ding, C. et al. Cellular delivery of relaxin-2 mRNA as a potential treatment for kidney fibrosis. Mater. Today Biol. 21, 100716 (2023).","DOI":"10.1016\/j.mtbio.2023.100716"},{"key":"51571_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2174\/1567201820666230407135026","volume":"21","author":"YJ Li","year":"2023","unstructured":"Li, Y. J. et al. Delivering relaxin plasmid by polymeric metformin lipid nanoparticles for liver fibrosis treatment. Curr. Drug Deliv. 21, 431\u2013437 (2023).","journal-title":"Curr. Drug Deliv."},{"key":"51571_CR36","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.jconrel.2016.01.007","volume":"240","author":"H Wahyudi","year":"2016","unstructured":"Wahyudi, H., Reynolds, A. A., Li, Y., Owen, S. C. & Yu, S. M. Targeting collagen for diagnostic imaging and therapeutic delivery. J. Control Release 240, 323\u2013331 (2016).","journal-title":"J. Control Release"},{"key":"51571_CR37","doi-asserted-by":"crossref","unstructured":"Briquez, P. S., Tsai, H. M., Watkins, E. A. & Hubbell, J. A. Engineered bridge protein with dual affinity for bone morphogenetic protein-2 and collagen enhances bone regeneration for spinal fusion. Sci. Adv. 7, eabh4302 (2021).","DOI":"10.1126\/sciadv.abh4302"},{"key":"51571_CR38","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1182\/blood.2019000510","volume":"133","author":"J Ishihara","year":"2019","unstructured":"Ishihara, J. et al. The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing. Blood 133, 2559\u20132569 (2019).","journal-title":"Blood"},{"key":"51571_CR39","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1021\/bm8006852","volume":"9","author":"JE Paderi","year":"2008","unstructured":"Paderi, J. E. & Panitch, A. Design of a synthetic collagen-binding peptidoglycan that modulates collagen fibrillogenesis. Biomacromolecules 9, 2562\u20132566 (2008).","journal-title":"Biomacromolecules"},{"key":"51571_CR40","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1002\/jbm.a.31179","volume":"82","author":"W Zhao","year":"2007","unstructured":"Zhao, W. et al. Vascularization and cellularization of collagen scaffolds incorporated with two different collagen-targeting human basic fibroblast growth factors. J. Biomed. Mater. Res. A 82, 630\u2013636 (2007).","journal-title":"J. Biomed. Mater. Res. A"},{"key":"51571_CR41","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.1039\/C5SC04754D","volume":"7","author":"MA Hossain","year":"2016","unstructured":"Hossain, M. A. et al. A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1. Chem. Sci. 7, 3805\u20133819 (2016).","journal-title":"Chem. Sci."},{"key":"51571_CR42","doi-asserted-by":"crossref","unstructured":"Hu, M. et al. Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy. Nat. Commun. 10, 2993(2019).","DOI":"10.1038\/s41467-019-10893-8"},{"key":"51571_CR43","doi-asserted-by":"crossref","unstructured":"Marques, A. C., Costa, P. C., Velho, S. & Amaral, M. H. Lipid nanoparticles functionalized with antibodies for anticancer drug therapy. Pharmaceutics 15, 216 (2023).","DOI":"10.3390\/pharmaceutics15010216"},{"key":"51571_CR44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.chembiol.2006.11.017","volume":"14","author":"S Streiff","year":"2007","unstructured":"Streiff, S. et al. Primitive\u201d membrane from polyprenyl phosphates and polyprenyl alcohols. Chem. Biol. 14, 313\u2013319 (2007).","journal-title":"Chem. Biol."},{"key":"51571_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2009.03.007","volume":"154","author":"RG Bennett","year":"2009","unstructured":"Bennett, R. G. Relaxin and its role in the development and treatment of fibrosis. Transl. Res. 154, 1\u20136 (2009).","journal-title":"Transl. Res."},{"key":"51571_CR46","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/bph.13695","volume":"174","author":"E Unemori","year":"2017","unstructured":"Unemori, E. Serelaxin in clinical development: past, present and future. Br. J. Pharmacol. 174, 921\u2013932 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"51571_CR47","first-page":"E3351","volume":"115","author":"MY Arteta","year":"2018","unstructured":"Arteta, M. Y. et al. Successful reprogramming of cellular protein production through mRNA delivered by functionalized lipid nanoparticles. Proc. Natl Acad. Sci. USA 115, E3351\u2013E3360 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"51571_CR48","doi-asserted-by":"crossref","unstructured":"Mok, J. H. et al. Optimizing MS-based multi-omics: comparative analysis of protein, metabolite, and lipid extraction techniques. Metabolites 14, 34 (2024).","DOI":"10.3390\/metabo14010034"},{"key":"51571_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1136\/gut.2005.071118","volume":"55","author":"K Tomita","year":"2006","unstructured":"Tomita, K. Tumour necrosis factor signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55, 415\u2013424 (2006).","journal-title":"Gut"},{"key":"51571_CR50","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.omtm.2020.07.011","volume":"18","author":"C Yang","year":"2020","unstructured":"Yang, C. et al. AAV-mediated ApoC2 gene therapy: reversal of severe hypertriglyceridemia and rescue of neonatal death in ApoC2-deficient hamsters. Mol. Ther. Methods Clin. Dev. 18, 692\u2013701 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"51571_CR51","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1164\/rccm.200110-026OC","volume":"166","author":"A Nemmar","year":"2002","unstructured":"Nemmar, A. et al. Ultrafine particles affect experimental thrombosis in an in vivo Hamster model. Am. J. Respir. Crit. Care Med. 166, 998\u20131004 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"51571_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1515\/mr-2021-0004","volume":"1","author":"G Liu","year":"2021","unstructured":"Liu, G., Lai, P., Guo, J., Wang, Y. & Xian, X. Genetically-engineered hamster models: applications and perspective in dyslipidemia and atherosclerosis-related cardiovascular disease. Med. Rev. 1, 92\u2013110 (2021).","journal-title":"Med. Rev."},{"key":"51571_CR53","doi-asserted-by":"publisher","unstructured":"Miranda, A. M. et al. Effects of APOE4 allelic dosage on lipidomic signatures in the entorhinal cortex of aged mice. Transl. Psychiatry 12, 129 https:\/\/doi.org\/10.1038\/s41398-022-01881-6 (2022).","DOI":"10.1038\/s41398-022-01881-6"},{"key":"51571_CR54","doi-asserted-by":"crossref","unstructured":"Zhang, J.-J., Cao, D.-Y., Yang, J.-X. & Shen, K. Ovarian metastasis from nongynecologic primary sites: a retrospective analysis of 177 cases and 13-year experience. J. Ovarian Res. 13, 128 (2020).","DOI":"10.1186\/s13048-020-00714-8"},{"key":"51571_CR55","doi-asserted-by":"publisher","first-page":"8958","DOI":"10.1021\/acs.analchem.2c00806","volume":"94","author":"YB Kim","year":"2022","unstructured":"Kim, Y. B., Lee, G. B. & Moon, M. H. Size separation of exosomes and microvesicles using flow field-flow fractionation\/multiangle light scattering and lipidomic comparison. Anal. Chem. 94, 8958\u20138965 (2022).","journal-title":"Anal. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51571-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51571-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51571-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,27]],"date-time":"2024-08-27T06:05:01Z","timestamp":1724738701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-51571-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,27]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["51571"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-51571-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3746897\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,27]]},"assertion":[{"value":"11 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M, X.Z.S., Z.Q.Z. have filed a patent for the development of the described FORT strategy. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7263"}}